Fjarde Ap-fonden’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29M Buy
461,370
+176,800
+62% +$14.1M 0.16% 126
2025
Q4
$27.1M Sell
284,570
-5,800
-2% -$569K 0.23% 91
2025
Q3
$28.3M Buy
290,370
+2,412
+0.8% +$250K 0.24% 84
2025
Q2
$30.9M Buy
287,958
+55,800
+24% +$5.65M 0.29% 75
2025
Q1
$23.4M Sell
232,158
-23,400
-9% -$2.36M 0.28% 70
2024
Q4
$22.8M Sell
255,558
-18,800
-7% -$1.65M 0.23% 85
2024
Q3
$23M Buy
+274,358
New +$21.6M 0.23% 83
2024
Q1
$17.7M Buy
258,058
+12,300
+5% +$791K 0.2% 111
2023
Q4
$14.2M Sell
245,758
-4,721
-2% -$252K 0.18% 125
2023
Q3
$13.2M Sell
250,479
-8,800
-3% -$462K 0.18% 121
2023
Q2
$14M Sell
259,279
-56,200
-18% -$2.94M 0.17% 128
2023
Q1
$15.8M Sell
315,479
-17,700
-5% -$834K 0.21% 113
2022
Q4
$15.4M Buy
333,179
+35,000
+12% +$1.52M 0.22% 114
2022
Q3
$11.1M Hold
298,179
0.14% 147
2022
Q2
$11.1M Sell
298,179
-101,600
-25% -$4.14M 0.14% 147
2022
Q1
$17.7M Sell
399,779
-37,806
-9% -$1.64M 0.17% 113
2021
Q4
$18.6M Sell
437,585
-8,300
-2% -$349K 0.16% 120
2021
Q3
$19.3M Sell
445,885
-14,900
-3% -$659K 0.18% 113
2021
Q2
$19.7M Sell
460,785
-30,700
-6% -$1.29M 0.18% 115
2021
Q1
$19M Buy
491,485
+10,500
+2% +$397K 0.17% 117
2020
Q4
$17.3M Buy
480,985
+52,500
+12% +$1.89M 0.16% 124
2020
Q3
$16.4M Buy
428,485
+31,000
+8% +$1.19M 0.18% 114
2020
Q2
$14M Buy
397,485
+16,800
+4% +$605K 0.18% 122
2020
Q1
$12.4M Sell
380,685
-13,600
-3% -$531K 0.2% 107
2019
Q4
$17.8M Buy
394,285
+13,900
+4% +$582K 0.22% 99
2019
Q3
$15.5M Sell
380,385
-6,236
-2% -$264K 0.2% 113
2019
Q2
$16.6M Sell
386,621
-28,600
-7% -$1.1M 0.21% 103
2019
Q1
$15.9M Buy
415,221
+80,825
+24% +$3.09M 0.2% 101
2018
Q4
$11.8M Sell
334,396
-38,800
-10% -$1.41M 0.2% 100
2018
Q3
$14.4M Sell
373,196
-12,819
-3% -$448K 0.21% 100
2018
Q2
$12.6M Buy
386,015
+10,325
+3% +$311K 0.19% 116
2018
Q1
$10.3M Sell
375,690
-6,582
-2% -$179K 0.16% 147
2017
Q4
$9.48M Buy
382,272
+61,460
+19% +$1.7M 0.14% 158
2017
Q3
$9.36M Buy
320,812
+295
+0.1% +$8.15K 0.18% 131
2017
Q2
$8.88M Buy
320,517
+43,975
+16% +$1.17M 0.18% 129
2017
Q1
$6.88M Sell
276,542
-20,313
-7% -$494K 0.16% 138
2016
Q4
$6.42M Sell
296,855
-26,456
-8% -$577K 0.15% 150
2016
Q3
$7.7M Buy
323,311
+10,353
+3% +$247K 0.17% 136
2016
Q2
$7.31M Buy
312,958
+5,455
+2% +$118K 0.17% 135
2016
Q1
$5.78M Buy
307,503
+38,149
+14% +$670K 0.13% 172
2015
Q4
$4.97M Buy
269,354
+6,670
+3% +$120K 0.13% 169
2015
Q3
$4.31M Sell
262,684
-23,489
-8% -$401K 0.12% 198
2015
Q2
$5.07M Sell
286,173
-11,374
-4% -$203K 0.12% 189
2015
Q1
$5.28M Sell
297,547
-26,724
-8% -$422K 0.12% 197
2014
Q4
$4.3M Sell
324,271
-14,928
-4% -$191K 0.09% 256
2014
Q3
$4.01M Sell
339,199
-30,094
-8% -$379K 0.09% 268
2014
Q2
$4.72M Sell
369,293
-7,546
-2% -$98.1K 0.09% 248
2014
Q1
$5.09M Buy
376,839
+13,715
+4% +$180K 0.1% 225
2013
Q4
$4.37M Sell
363,124
-28,678
-7% -$339K 0.09% 257
2013
Q3
$4.6M Sell
391,802
-30,683
-7% -$332K 0.1% 234
2013
Q2
$3.92M Buy
+422,485
New +$3.58M 0.08% 294

Other funds holding BSX